5min chapter

Breakpoints cover image

#68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials

Breakpoints

CHAPTER

ABX01 - A Novel Immunotherapy to Treat Gram Negative Infections

A novel immunotherapy to treat gram negative infections developed by Centari therapeutics called ABX01. This is still in the molecule number and letter phase, but very, very excited. And they looked at this using knockout mice so that neutropenic mice and they saw about a two log drop in bacterial colony forming units alone. They added in the antibody response and they got an additional three log kill. It's remniscent of some of the data we talked about in early ECMA episodes from a couple of years ago about using these immunotherapies as adjunct agents for bacteremia.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode